T. Rowe Price Associates’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-11,678
| Closed | -$131K | – | 2909 |
|
2023
Q3 | $131K | Buy |
+11,678
| New | +$131K | ﹤0.01% | 2604 |
|
2023
Q2 | – | Sell |
-162,694
| Closed | -$6.58M | – | 2900 |
|
2023
Q1 | $6.58M | Sell |
162,694
-11,609
| -7% | -$470K | ﹤0.01% | 1124 |
|
2022
Q4 | $8.11M | Sell |
174,303
-66,384
| -28% | -$3.09M | ﹤0.01% | 1091 |
|
2022
Q3 | $12.5M | Buy |
240,687
+52,344
| +28% | +$2.72M | ﹤0.01% | 1022 |
|
2022
Q2 | $8.9M | Sell |
188,343
-4,716
| -2% | -$223K | ﹤0.01% | 1336 |
|
2022
Q1 | $13.7M | Sell |
193,059
-81,258
| -30% | -$5.78M | ﹤0.01% | 1318 |
|
2021
Q4 | $20.5M | Buy |
274,317
+12,194
| +5% | +$912K | ﹤0.01% | 1282 |
|
2021
Q3 | $14.9M | Buy |
262,123
+9,341
| +4% | +$531K | ﹤0.01% | 1365 |
|
2021
Q2 | $11.1M | Sell |
252,782
-611,479
| -71% | -$26.9M | ﹤0.01% | 1401 |
|
2021
Q1 | $42.6M | Sell |
864,261
-97,184
| -10% | -$4.79M | ﹤0.01% | 1052 |
|
2020
Q4 | $40.5M | Sell |
961,445
-12,984
| -1% | -$547K | ﹤0.01% | 1031 |
|
2020
Q3 | $44.6M | Sell |
974,429
-308,128
| -24% | -$14.1M | 0.01% | 910 |
|
2020
Q2 | $64.4M | Sell |
1,282,557
-72,381
| -5% | -$3.63M | 0.01% | 765 |
|
2020
Q1 | $69.7M | Sell |
1,354,938
-41,397
| -3% | -$2.13M | 0.01% | 685 |
|
2019
Q4 | $86.3M | Sell |
1,396,335
-158,917
| -10% | -$9.82M | 0.01% | 713 |
|
2019
Q3 | $93.4M | Buy |
1,555,252
+26,711
| +2% | +$1.6M | 0.01% | 646 |
|
2019
Q2 | $129M | Buy |
1,528,541
+159,504
| +12% | +$13.5M | 0.02% | 581 |
|
2019
Q1 | $131M | Buy |
1,369,037
+295,615
| +28% | +$28.2M | 0.02% | 567 |
|
2018
Q4 | $76M | Buy |
1,073,422
+10,338
| +1% | +$732K | 0.01% | 679 |
|
2018
Q3 | $90.9M | Buy |
1,063,084
+207,593
| +24% | +$17.7M | 0.01% | 701 |
|
2018
Q2 | $99.2M | Buy |
855,491
+537,087
| +169% | +$62.2M | 0.02% | 660 |
|
2018
Q1 | $25.8M | Sell |
318,404
-53,606
| -14% | -$4.34M | ﹤0.01% | 1094 |
|
2017
Q4 | $21.8M | Buy |
372,010
+269,566
| +263% | +$15.8M | ﹤0.01% | 1148 |
|
2017
Q3 | $4.79M | Buy |
+102,444
| New | +$4.79M | ﹤0.01% | 1427 |
|